U.S. Markets closed

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.06000.0000 (0.00%)
At close: 04:00PM EDT
2.0600 0.00 (0.00%)
After hours: 04:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.57
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.8000
52 Week Low 32.0600
50-Day Moving Average 32.9511
200-Day Moving Average 33.2618

Share Statistics

Avg Vol (3 month) 3153.6k
Avg Vol (10 day) 3106.97k
Shares Outstanding 568.09M
Implied Shares Outstanding 6N/A
Float 835.23M
% Held by Insiders 123.37%
% Held by Institutions 150.16%
Shares Short (Apr 28, 2022) 4672.7k
Short Ratio (Apr 28, 2022) 44.8
Short % of Float (Apr 28, 2022) 41.14%
Short % of Shares Outstanding (Apr 28, 2022) 40.96%
Shares Short (prior month Mar 30, 2022) 4735k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 58.95%
Operating Margin (ttm)59.61%

Management Effectiveness

Return on Assets (ttm)57.40%
Return on Equity (ttm)109.98%

Income Statement

Revenue (ttm)208.38M
Revenue Per Share (ttm)3.09
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)208.38M
EBITDA 124.45M
Net Income Avi to Common (ttm)119.84M
Diluted EPS (ttm)1.8390
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)187.8M
Total Cash Per Share (mrq)2.67
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)12.87
Book Value Per Share (mrq)2.90

Cash Flow Statement

Operating Cash Flow (ttm)118.61M
Levered Free Cash Flow (ttm)75.6M